Monday, November 14 at 11:30AM EST

PPMD will be hosting a webinar on Monday, November 14 at 11:30AM EST with Masters Pharmaceuticals.

Join PPMD’s President & CEO Pat Furlong and SVP of Clinical Care Kathi Kinnett in a conversation with Masters’ CEO Zulf Masters.

The discussion will be around the transition from Masters’ deflazacort to Marathon Pharmaceuticals deflazacort, should Marathon receive approval in the U.S.

Speakers:

• Pat Furlong, President & CEO, PPMD
• Kathi Kinnett, SVP of Clinical Care, PPMD
• Zulf Masters, CEO, Masters Pharmaceuticals

To Participate:

1. Visit ReadyTalk.com and use participant code 9449985. (Be sure to test your computer beforehand)
2. Audio Dial-In Information:
   • U.S. & Canada: Dial 1.866.740.1260 and use the Access Code 9449985
   • Outside the U.S. and Canada: Lookup your number

Submit Questions:

Please submit questions in advance to info@parentprojectmd.org, with “Deflazacort Webinar” in the subject line by noon on Friday, 11/11.